GelStat Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Net Income before Extraordinaries
275.70
296.50
464.10
407.40
1,297.50
Depreciation, Depletion & Amortization
1.30
1.30
1.30
1.40
57.90
Other Funds
205.40
162.00
794.20
250.20
932.30
Funds from Operations
69.00
133.20
328.80
155.70
307.40
Changes in Working Capital
58.30
89.10
105.60
10.30
68.20
Net Operating Cash Flow
38.90
315.10
223.20
145.40
239.20
Capital Expenditures
-
-
-
9.50
4.60
Net Investing Cash Flow
-
-
-
9.50
197.10
Issuance/Reduction of Debt, Net
4.80
40.10
0.70
-
51.60
Net Financing Cash Flow
37.30
317.40
221.80
249.00
437.90
Net Change in Cash
1.60
2.30
1.40
94.10
1.60
Free Cash Flow
38.90
315.10
223.20
148.00
243.70
Net Assets from Acquisitions
-
-
-
-
225.00
Other Sources
-
-
-
-
32.40
Change in Capital Stock
32.50
357.50
222.50
249.00
489.50
Extraordinaries
28.20
271.00
-
-
-

About GelStat

View Profile
Address
10711 Gilroy Road
Hunt Valley Maryland 21031
United States
Employees -
Website http://www.gelstat.com
Updated 07/08/2019
GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes GelStat Migraine, Chews 2 Lose, All Natural Speed, and GelStat Speed. The company was founded on November 13, 1991 and is headquartered in Hunt Valley, MD.